Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Breast Diseases × Genotype × Clear all

Status

Active not recruiting 1

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 4 Pancreatic Neoplasms 2 Thyroid Cancer, Papillary 1 Myasthenia Gravis 1 Kidney Neoplasms 1 Glioblastoma 1 Fanconi Anemia, Complementation Group D1 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma, Intraductal, Noninfiltrating 1 Breast Diseases 1 Breast Carcinoma In Situ 1

Interventions

palbociclib 5 Trastuzumab 5 Fulvestrant 5 Docetaxel 5 Anastrozole 5 exemestane 4 Letrozole 4 ribociclib 3 pyrotinib 3 entinostat 3 abemaciclib 3 Cyclophosphamide 3 Sodium Chloride 2 Paclitaxel 2 Lapatinib 2 Exercise 2 Everolimus 2 Capecitabine 2 Botulinum Toxins, Type A 2 tucatinib 1 sacubitril and valsartan sodium hydrate drug combination 1 pertuzumab 1 pembrolizumab 1 pegfilgrastim 1 ipatasertib 1 gadoterate meglumine 1 figitumumab 1 elacestrant 1 dactolisib 1 atezolizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05006196 2025-12-01

IMOGEN

Perspectum

Active not recruiting

Breast Diseases, Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡